March 16, 2020 / 12:21 PM / 16 days ago

BRIEF-Eagle Pharmaceuticals - U.S. Court Affirmed Decision Requiring FDA To Grant Co, 7 Years Of Orphan Drug Exclusivity In U.S. For Bendeka

March 16 (Reuters) - Eagle Pharmaceuticals Inc:

* EAGLE PHARMACEUTICALS - ON MARCH 13, U.S. COURT AFFIRMED DECISION REQUIRING FDA TO GRANT CO, 7 YEARS OF ORPHAN DRUG EXCLUSIVITY IN U.S. FOR BENDEKA Source text for Eikon: bit.ly/3aWM3Mb Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below